22nd Century Group Revenue and Competitors

Buffalo, NY USA

Location

$18.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • 22nd Century Group's estimated annual revenue is currently $300M per year.(i)
  • 22nd Century Group's estimated revenue per employee is $5,555,556
  • 22nd Century Group's total funding is $18.7M.

Employee Data

  • 22nd Century Group has 54 Employees.(i)
  • 22nd Century Group grew their employee count by 46% last year.

22nd Century Group's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Chief Analytics OfficerReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Legal Officer and SecretaryReveal Email/Phone
5
Chief Analytics OfficerReveal Email/Phone
6
Chief Scientific OfficerReveal Email/Phone
7
Chief Legal Officer and SecretaryReveal Email/Phone
8
VP SalesReveal Email/Phone
9
General Counsel and Corporate SecretaryReveal Email/Phone
10
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is 22nd Century Group?

22nd Century is a plant biotechnology company and the global leader in modifying the content of nicotinic alkaloids in plants, including the tobacco plant, through genetic engineering and plant breeding. The company develops innovative plant lines with combinations of new and/or enhanced traits. We own or exclusively control 97 issued patents in 79 countries where at least 75% of the world\'s smokers reside. 22nd Century\'s business segments are primarily smoking cessation products and modified risk tobacco products.

keywords:N/A

$18.7M

Total Funding

54

Number of Employees

$300M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

22nd Century Group News

2022-04-20 - 22nd Century Launches its Low-Nicotine Cigarettes in Illinois

22nd Century Group's VLN cigarettes are now available through a national pilot in select Chicagoland Circle K stores, the company announced...

2022-04-17 - 22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022

BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company...

2022-03-30 - FDA Authorized Reduced-Nicotine Cigarette from 22nd ...

BUFFALO, N.Y., March 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M548%N/A
#2
$13.1M544%N/A
#3
$11.8M544%N/A
#4
N/A5522%$9M
#5
$10.9M55-7%N/A